• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Eurofins BioPharma Product Testing

europeanpharmaceuticalreviewJune 17, 2019

Tag: product , GMP , Biopharma , Eurofins , Testing

From starting materials through to finished product testing, Eurofins BioPharma Product Testing’s 34 facilities in 17 countries deliver a comprehensive scope of harmonised GMP testing services and seamless regulatory acceptance.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com

Previous:Whitepaper: VIVAPUR® MCG – a powerful stabiliser for nasal sprays

Next:Blueprint Medicines Submits New Drug Application to U.S. Food and Drug Administration for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST

Related News

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

BioPharmaSpec, the leading global Contract Research Organization (CRO) for Discovery and Preclinical Characterization of Biopharmaceuticals, has officially announced three new European facilities.

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Eurofins BioPharma Product Testing | Pharmasources.com

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may like
More>>

Non-PVC Soft Bag IV Solution Production Line

Non-PVC Soft Bag IV Solution Production Line
Sterility testing pump disposable bags

Sterility testing pump disposable bags
98% up GMP DMF Testosterone 58-22-0

98% up GMP DMF Testosterone 58-22-0
Pharmaceutical Multifunctional SUS316 Extraction Production Units plant extract tank

Pharmaceutical Multifunctional SUS316 Extraction Production Units plant extract tank
99% up GMP DMF Ranitidine hydrochloride 66357-35-5

99% up GMP DMF Ranitidine hydrochloride 66357-35-5
99% up GMP DMF Pantoprazole 102625-70-7

99% up GMP DMF Pantoprazole 102625-70-7
leak testing methods

leak testing methods
China product chili oil and cooking oil

China product chili oil and cooking oil

microbial limits testing

microbial limits testing
99% up GMP DMF Cilastatin Sodium 81129-83-1

99% up GMP DMF Cilastatin Sodium 81129-83-1

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service